Abnormal dopamine transporter (DAT) uptake is an important biomarker for the clinical diagnosis of Lewy body disease (LBD), including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB). This evidence concerns the gene SLC6A3 and Lewy body dementia.